GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 421 filers reported holding GUARDANT HEALTH INC in Q1 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $814,000 | +98.1% | 15,124 | +48.2% | 0.00% | – |
| Q2 2022 | $411,000 | -93.3% | 10,207 | -89.0% | 0.00% | -100.0% |
| Q1 2022 | $6,139,000 | -23.9% | 92,700 | +8.7% | 0.01% | -16.7% |
| Q4 2021 | $8,071,000 | -9.7% | 85,261 | +13.4% | 0.01% | -25.0% |
| Q3 2021 | $8,941,000 | +29.5% | 75,197 | +28.2% | 0.01% | +33.3% |
| Q2 2021 | $6,904,000 | -16.6% | 58,655 | +2.5% | 0.01% | -25.0% |
| Q1 2021 | $8,276,000 | +28.5% | 57,241 | +8.9% | 0.01% | +14.3% |
| Q4 2020 | $6,441,000 | +61.7% | 52,583 | +38.2% | 0.01% | +40.0% |
| Q3 2020 | $3,984,000 | -9.4% | 38,043 | -31.3% | 0.01% | 0.0% |
| Q2 2020 | $4,397,000 | +29.8% | 55,346 | +13.7% | 0.01% | 0.0% |
| Q1 2020 | $3,387,000 | +19.0% | 48,671 | +33.7% | 0.01% | +66.7% |
| Q4 2019 | $2,846,000 | -66.3% | 36,414 | -72.5% | 0.00% | -70.0% |
| Q3 2019 | $8,457,000 | -23.9% | 132,502 | +2.9% | 0.01% | -23.1% |
| Q2 2019 | $11,112,000 | – | 128,718 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |